349 related articles for article (PubMed ID: 34801748)
21. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
Nascimento Júnior JAC; Santos AM; Cavalcante RCM; Quintans-Júnior LJ; Walker CIB; Borges LP; Frank LA; Serafini MR
Drug Dev Ind Pharm; 2021 Apr; 47(4):673-684. PubMed ID: 33826439
[TBL] [Abstract][Full Text] [Related]
22. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
23. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.
Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP
Front Immunol; 2022; 13():1056272. PubMed ID: 36618428
[TBL] [Abstract][Full Text] [Related]
25. Receptor-binding domain-based subunit vaccines against MERS-CoV.
Zhang N; Tang J; Lu L; Jiang S; Du L
Virus Res; 2015 Apr; 202():151-9. PubMed ID: 25445336
[TBL] [Abstract][Full Text] [Related]
26. From SARS to MERS, Thrusting Coronaviruses into the Spotlight.
Song Z; Xu Y; Bao L; Zhang L; Yu P; Qu Y; Zhu H; Zhao W; Han Y; Qin C
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646565
[TBL] [Abstract][Full Text] [Related]
27. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
Kato T; Takami Y; Kumar Deo V; Park EY
J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
[TBL] [Abstract][Full Text] [Related]
28. A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge.
Park JE; Kim JH; Park JY; Jun SH; Shin HJ
Virol J; 2022 Jun; 19(1):112. PubMed ID: 35761402
[TBL] [Abstract][Full Text] [Related]
29. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
30. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
31. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B
mBio; 2020 Apr; 11(2):. PubMed ID: 32265331
[TBL] [Abstract][Full Text] [Related]
32. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.
Alharbi NK; Padron-Regalado E; Thompson CP; Kupke A; Wells D; Sloan MA; Grehan K; Temperton N; Lambe T; Warimwe G; Becker S; Hill AVS; Gilbert SC
Vaccine; 2017 Jun; 35(30):3780-3788. PubMed ID: 28579232
[TBL] [Abstract][Full Text] [Related]
33. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
34. MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges.
Rabaan AA; Al-Ahmed SH; Sah R; Alqumber MA; Haque S; Patel SK; Pathak M; Tiwari R; Yatoo MI; Haq AU; Bilal M; Dhama K; Rodriguez-Morales AJ
Ann Clin Microbiol Antimicrob; 2021 Jan; 20(1):8. PubMed ID: 33461573
[TBL] [Abstract][Full Text] [Related]
35. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
36. Potential Drug Strategies to Target Coronaviruses.
Sarkar K; Sil PC
Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597
[TBL] [Abstract][Full Text] [Related]
37. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
[TBL] [Abstract][Full Text] [Related]
38. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.
Aljabr W; Alruwaili M; Penrice-Randal R; Alrezaihi A; Harrison AJ; Ryan Y; Bentley E; Jones B; Alhatlani BY; AlShahrani D; Mahmood Z; Rickett NY; Alosaimi B; Naeem A; Alamri S; Alsran H; Hamed ME; Dong X; Assiri AM; Alrasheed AR; Hamza M; Carroll MW; Gemmell M; Darby A; Donovan-Banfield I; Stewart JP; Matthews DA; Davidson AD; Hiscox JA
mSphere; 2021 Aug; 6(4):e0021921. PubMed ID: 34287009
[TBL] [Abstract][Full Text] [Related]
39. Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach.
Khan T; Khan A; Ansari JK; Najmi MH; Wei DQ; Muhammad K; Waheed Y
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408772
[TBL] [Abstract][Full Text] [Related]
40. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y; Yang Y; Huang J; Jiang S; Du L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]